To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous ...

Increases speed to market for drug developers working on nucleic acid therapeutics.

Essex Management, an Emmes Group company, has appointed David Loose as Chief Executive Officer (CEO), effective immediately.

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed Joerg Moeller, MD, PhD ...

NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have formed a partnership to develop and manufacture ...

Galapagos plans to discontinue its small molecule discovery programs and seek potential partners to take over these assets, ...

Tarsier Pharma, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing ...

The companies entered the agreement in 2023 to jointly advance as many as 11 drug programs, mainly targeting cardiovascular ...

Mytos, a provider of automated cell manufacturing, has entered a manufacturing collaboration with Aspen Neuroscience, Inc. to ...

The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...